303 related articles for article (PubMed ID: 17047891)
1. Excellent response to the clinical treatment of tophaceous gout.
Caldas CA; Fuller R
Clin Rheumatol; 2007 Sep; 26(9):1553-5. PubMed ID: 17047891
[TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout.
Perez-Ruiz F; Hernandez-Baldizon S; Herrero-Beites AM; Gonzalez-Gay MA
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1299-305. PubMed ID: 20506124
[TBL] [Abstract][Full Text] [Related]
3. Influence of urate-lowering therapies on renal handling of uric acid.
Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.
Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Herrero-Beites A; García-Erauskin G; Ruiz-Lucea E
Ann Rheum Dis; 1998 Sep; 57(9):545-9. PubMed ID: 9849314
[TBL] [Abstract][Full Text] [Related]
5. Uricosuric medications for chronic gout.
Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
[TBL] [Abstract][Full Text] [Related]
6. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
[TBL] [Abstract][Full Text] [Related]
7. Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients.
Chung TT; Yu KH; Kuo CF; Luo SF; Chiou MJ; Lan WC; Chen JS; Tseng WY; Hsieh AH; Wang LC
Arthritis Res Ther; 2019 Sep; 21(1):210. PubMed ID: 31533805
[TBL] [Abstract][Full Text] [Related]
8. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.
Reinders MK; Haagsma C; Jansen TL; van Roon EN; Delsing J; van de Laar MA; Brouwers JR
Ann Rheum Dis; 2009 Jun; 68(6):892-7. PubMed ID: 18633127
[TBL] [Abstract][Full Text] [Related]
9. Prevention of comorbidity and acute attack of gout by uric acid lowering therapy.
Joo K; Kwon SR; Lim MJ; Jung KH; Joo H; Park W
J Korean Med Sci; 2014 May; 29(5):657-61. PubMed ID: 24851021
[TBL] [Abstract][Full Text] [Related]
10. Effect of allopurinol and benzbromarone on the concentration of uridine in plasma.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
Metabolism; 1997 Dec; 46(12):1473-6. PubMed ID: 9439546
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of uric acid-lowering therapy on hypercholesterolemia and hypertriglyceridemia in gouty patients.
Wu J; Zhang YP; Qu Y; Jie LG; Deng JX; Yu QH
Int J Rheum Dis; 2019 Aug; 22(8):1445-1451. PubMed ID: 31317680
[TBL] [Abstract][Full Text] [Related]
12. [Hyperuricemia and gout--treatment].
Gröbner W; Walter-Sack I
Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
[No Abstract] [Full Text] [Related]
13. Clinical images: Divergent patterns of joint remodeling following effective urate-lowering therapy in tophaceous gout.
Dalbeth N; Doyle A; McQueen FM
Arthritis Rheum; 2011 Jan; 63(1):266. PubMed ID: 20722028
[No Abstract] [Full Text] [Related]
14. How should we treat tophaceous gout in patients with allopurinol hypersensitivity?
Grahame R; Simmonds HA; McBride MB; Marsh FP
Adv Exp Med Biol; 1998; 431():19-23. PubMed ID: 9598024
[TBL] [Abstract][Full Text] [Related]
15. [Summary of the Dutch College of General Practitioners' "Gout" Standard].
Romeijnders AC; Gorter KJ
Ned Tijdschr Geneeskd; 2002 Feb; 146(7):309-13. PubMed ID: 11876034
[TBL] [Abstract][Full Text] [Related]
16. [Gout: physiopathology, diagnosis, course, treatment].
Chazerain P; Ziza JM
Rev Prat; 1998 Sep; 48(13):1453-6. PubMed ID: 10050628
[No Abstract] [Full Text] [Related]
17. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout.
van Lieshout-Zuidema MF; Breedveld FC
J Rheumatol; 1993 Aug; 20(8):1383-5. PubMed ID: 8230024
[TBL] [Abstract][Full Text] [Related]
18. Renal handling of urate in a patient with familial juvenile gouty nephropathy.
Hisatome I; Kosaka H; Ohtahara K; Tsuboi M; Manabe I; Ohtahara A; Sawaguchi M; Igawa O; Tanaka Y; Fujimoto Y; Yoshida A; Takeda A; Shigemasa C
Intern Med; 1996 Jul; 35(7):564-8. PubMed ID: 8842764
[TBL] [Abstract][Full Text] [Related]
19. [Familial gout and nephropathy in a young woman. Report of one case].
Badilla A; Rojas C
Rev Med Chil; 2001 Jun; 129(6):666-70. PubMed ID: 11510209
[TBL] [Abstract][Full Text] [Related]
20. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
Zöllner N; Griebsch A; Fink JK
Dtsch Med Wochenschr; 1970 Nov; 95(48):2405-12. PubMed ID: 5480261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
